Using AMBP results, LTP supplementation showed a tendency for reduction in both SBP (−0.94 mmHg, 95% CI: −2.06, 0.18, p = 0.101) and DBP (−0.46 mmHg, 95% CI: −1.11, 0.19, p = 0.166) although this did not reach statistical significance.
← all excerpts
Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials.
1
—
—